AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 23121439 — intervention group
Group type: EXPERIMENTAL
Intervention: Platelet-function monitoring with drug adjustment in patients with poor response to antiplatelet therapy.
Number of subjects: 2440
Study 23121439 — intervention group
Group type: COMPARATOR
Intervention: Conventional strategy without monitoring and drug adjustment.
Number of subjects: 2440
Study 23121439 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (monitoring and conventional treatment).
Number of subjects: 2440
Study 19758398 — intervention group
Group type: EXPERIMENTAL
Intervention: Ondansetron 0.2 mg/kg
Number of subjects: 109
Study 19758398 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 109
Study 18547842 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluid transport model
Number of subjects: 80
Study 18547842 — intervention group
Group type: EXPERIMENTAL
Intervention: Glucose penetration model
Number of subjects: 80
Study 15839595 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgical microscope (test group)
Number of subjects: 24
Study 15839595 — intervention group
Group type: COMPARATOR
Intervention: Conventional techniques (control group)
Number of subjects: 24
Study 15839595 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 24
Study 12894046 — intervention group
Group type: EXPERIMENTAL
Intervention: Phenoxymethyl penicillin V plus antioxidant vitamins for eight weeks
Number of subjects: 606
Study 12894046 — intervention group
Group type: COMPARATOR
Intervention: Phenoxymethyl penicillin V
Number of subjects: 606
Study 10589108 — intervention group
Group type: EXPERIMENTAL
Intervention: Quick Relaxation Technique (QRT) in conjunction with analgesics
Number of subjects: 24
Study 10589108 — intervention group
Group type: EXPERIMENTAL
Intervention: Quick Relaxation Technique (QRT)
Number of subjects: 24
Study 10589108 — intervention group
Group type: COMPARATOR
Intervention: Analgesics without relaxation exercises
Number of subjects: 24
Study 9003882 — intervention group
Group type: EXPERIMENTAL
Intervention: Glucose energy supplementation
Number of subjects: 106
Study 9003882 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin supplementation
Number of subjects: 106
Study 9003882 — intervention group
Group type: COMPARATOR
Intervention: Placebo (control)
Number of subjects: 106
Study 1290186 — intervention group
Group type: EXPERIMENTAL
Intervention: Amrinone
Number of subjects: 19
Study 1290186 — intervention group
Group type: EXPERIMENTAL
Intervention: Enoximone
Number of subjects: 19
Study 6506368 — intervention group
Group type: EXPERIMENTAL
Intervention: emepronium bromide (Cetiprin) 200 mg 4 times a day
Number of subjects: 75
Study 6506368 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 75
Study 31015165 — intervention group
Group type: EXPERIMENTAL
Intervention: SRT (5 × 5 Gy surgery within one week)
Number of subjects: 840
Study 31015165 — intervention group
Group type: EXPERIMENTAL
Intervention: SRT-delay (5 × 5 Gy with surgery after 4–8 weeks)
Number of subjects: 840
Study 31015165 — intervention group
Group type: EXPERIMENTAL
Intervention: LRT-delay (2 Gy × 25 with surgery after 4–8 weeks)
Number of subjects: 840
Study 31015165 — intervention group
Group type: COMPARATOR
Intervention: pCR vs no-pCR
Number of subjects: 840
Study 30532289 — intervention group
Group type: EXPERIMENTAL
Intervention: Inactivated BRSV vaccine
Number of subjects: 18
Study 30532289 — intervention group
Group type: EXPERIMENTAL
Intervention: Modified-live (MLV) BRSV vaccine
Number of subjects: 18
Study 30532289 — intervention group
Group type: COMPARATOR
Intervention: Control group (MLV only)
Number of subjects: 18
Study 28569933 — intervention group
Group type: EXPERIMENTAL
Intervention: Calculation Medicines - CalcMed application, n=50
Number of subjects: 100
Study 28569933 — intervention group
Group type: COMPARATOR
Intervention: Conventional method of calculator use and pre-math skills, n=50
Number of subjects: 100
Study 24495406 — intervention group
Group type: EXPERIMENTAL
Intervention: Trazodone 50 mg once daily at 10:00 P.M. for 2 weeks
Number of subjects: 30
Study 24495406 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study 24495406 — intervention group
Group type: COMPARATOR
Intervention: Trazodone and Placebo
Number of subjects: 30
Study 20368384 — intervention group
Group type: EXPERIMENTAL
Intervention: Progressive 24-wk exercise intervention
Number of subjects: 41
Study 20368384 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 41
Study 18936569 — intervention group
Group type: EXPERIMENTAL
Intervention: Corticosteroid withdrawal (CSWD)
Number of subjects: 386
Study 18936569 — intervention group
Group type: COMPARATOR
Intervention: Chronic low dose corticosteroid therapy (CCS)
Number of subjects: 386
Study 16101168 — intervention group
Group type: EXPERIMENTAL
Intervention: Epoetin alfa 40,000 IU subcutaneously once weekly plus oral iron 200 mg elemental iron once daily
Number of subjects: 100
Study 16101168 — intervention group
Group type: COMPARATOR
Intervention: Oral iron 200 mg elemental iron once daily
Number of subjects: 100
Study 11843741 — intervention group
Group type: EXPERIMENTAL
Intervention: Sevoflurane
Number of subjects: 41
Study 11843741 — intervention group
Group type: COMPARATOR
Intervention: Propofol (Control)
Number of subjects: 41
Study 10510925 — intervention group
Group type: EXPERIMENTAL
Intervention: finasteride 5 mg
Number of subjects: 3040
Study 10510925 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 3040
Study 8184044 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose thin-section CT (80-mAs)
Number of subjects: 50
Study 8184044 — intervention group
Group type: EXPERIMENTAL
Intervention: Conventional-dose thin-section CT (340-mAs)
Number of subjects: 50
Study 8184044 — intervention group
Group type: COMPARATOR
Intervention: Chest radiography
Number of subjects: 50
Study 3213066 — intervention group
Group type: EXPERIMENTAL
Intervention: Ferrum in combination with folic acid
Number of subjects: 30
Study 3213066 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 30
Study 31955155 — intervention group
Group type: EXPERIMENTAL
Intervention: Active dTMS treatment at 120% resting motor threshold with 18 Hz over the left dorsolateral prefrontal cortex, 1,980 pulses a day, 5 days a week, for 4-6 weeks
Number of subjects: 40
Study 31955155 — intervention group
Group type: COMPARATOR
Intervention: Sham dTMS treatment
Number of subjects: 40
Study 30501868 — intervention group
Group type: EXPERIMENTAL
Intervention: Dose-adjusted EPOCH-R (DA-EPOCH-R) administered for six cycles with CNS prophylaxis
Number of subjects: 53
Study 30501868 — intervention group
Group type: EXPERIMENTAL
Intervention: Toxicity profile of DA-EPOCH-R
Number of subjects: 53
Study 28775182 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-mydriatic ultra-wide field (NM UWF) imaging on the day of their clinic visit
Number of subjects: 740
Study 28775182 — intervention group
Group type: COMPARATOR
Intervention: Usual screening (encouraged to arrange an exam by an optometrist)
Number of subjects: 740
Study 24407549 — intervention group
Group type: EXPERIMENTAL
Intervention: Rubber interdental bristle (Fuchs®)
Number of subjects: 39
Study 24407549 — intervention group
Group type: COMPARATOR
Intervention: Metal-core interdental brush (TePe®)
Number of subjects: 39
Study 22170628 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypofractionated stereotactic body radiotherapy (CyberKnife) - 7.5 Gy in 5 fractions
Number of subjects: 45
Study 22170628 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypofractionated stereotactic body radiotherapy (CyberKnife) - 7.25 Gy in 5 fractions
Number of subjects: 45
Study 22170628 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypofractionated stereotactic body radiotherapy (CyberKnife) - other regimens
Number of subjects: 45
Study 22170628 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypofractionated stereotactic body radiotherapy (CyberKnife)
Number of subjects: 45
Study 20588098 — intervention group
Group type: EXPERIMENTAL
Intervention: Habituation exercises
Number of subjects: 7
Study 20588098 — intervention group
Group type: EXPERIMENTAL
Intervention: Gaze stability (GS) adaptation exercises
Number of subjects: 7
Study 18362256 — intervention group
Group type: EXPERIMENTAL
Intervention: New interventions
Number of subjects: 216451
Study 18362256 — intervention group
Group type: EXPERIMENTAL
Intervention: New treatments
Number of subjects: 216451
Study 18362256 — intervention group
Group type: EXPERIMENTAL
Intervention: Statistically significant trials favoring new or standard treatments
Number of subjects: 216451
Study 15768924 — intervention group
Group type: EXPERIMENTAL
Intervention: Union membership
Number of subjects: 1109
Study 15768924 — intervention group
Group type: EXPERIMENTAL
Intervention: Focus group discussions
Number of subjects: 1109
Study 12208639 — intervention group
Group type: EXPERIMENTAL
Intervention: Achievement stress condition (mathematical and verbal challenge)
Number of subjects: 50
Study 12208639 — intervention group
Group type: EXPERIMENTAL
Intervention: Social rejection stress condition (two social interaction challenges)
Number of subjects: 50
Study 10333895 — intervention group
Group type: EXPERIMENTAL
Intervention: Nurse case management
Number of subjects: 133
Study 10333895 — intervention group
Group type: COMPARATOR
Intervention: Baseline ACE inhibitor usage
Number of subjects: 133
Study 10333895 — intervention group
Group type: COMPARATOR
Intervention: Baseline screening practices
Number of subjects: 133
Study 8700963 — intervention group
Group type: EXPERIMENTAL
Intervention: High-protein strawberry yogurt
Number of subjects: 0
Study 8700963 — intervention group
Group type: EXPERIMENTAL
Intervention: High-protein sandwich
Number of subjects: 0
Study 8700963 — intervention group
Group type: EXPERIMENTAL
Intervention: High-protein meals
Number of subjects: 0
Study 8700963 — intervention group
Group type: COMPARATOR
Intervention: Low-protein meals
Number of subjects: 0
Study 1381639 — intervention group
Group type: EXPERIMENTAL
Intervention: Teicoplanin
Number of subjects: 0
Study 6743785 — intervention group
Group type: EXPERIMENTAL
Intervention: 50 mg oral solution
Number of subjects: 30
Study 6743785 — intervention group
Group type: EXPERIMENTAL
Intervention: 50 mg rectal suppository
Number of subjects: 30
Study 6743785 — intervention group
Group type: COMPARATOR
Intervention: 50 mg intramuscular injection
Number of subjects: 30
Study 31529007 — intervention group
Group type: EXPERIMENTAL
Intervention: Behavioral and pelvic floor muscle therapy combined with midurethral sling (n=209)
Number of subjects: 480
Study 31529007 — intervention group
Group type: COMPARATOR
Intervention: Sling alone (n=207)
Number of subjects: 480
Study 31529007 — intervention group
Group type: COMPARATOR
Intervention: Between-group comparison
Number of subjects: 480
Study 29116540 — intervention group
Group type: EXPERIMENTAL
Intervention: OCT20
Number of subjects: 986
Study 29116540 — intervention group
Group type: EXPERIMENTAL
Intervention: OCT30
Number of subjects: 986
Study 29116540 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 986
Study 26004044 — intervention group
Group type: EXPERIMENTAL
Intervention: Modified exponential taper
Number of subjects: 27
Study 26004044 — intervention group
Group type: EXPERIMENTAL
Intervention: Normal exponential taper
Number of subjects: 27
Study 26004044 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 27
Study 25146509 — intervention group
Group type: EXPERIMENTAL
Intervention: Prone position ventilation combined with recruitment maneuvers (RM) for at least 10 hours
Number of subjects: 116
Study 25146509 — intervention group
Group type: COMPARATOR
Intervention: Control group (supine position)
Number of subjects: 116
Study 21440398 — intervention group
Group type: EXPERIMENTAL
Intervention: Rectally insufflated CO2 with gadolinium-based tagging (A)
Number of subjects: 14
Study 21440398 — intervention group
Group type: EXPERIMENTAL
Intervention: Rectally insufflated CO2 with bowel purgation (B)
Number of subjects: 14
Study 21440398 — intervention group
Group type: EXPERIMENTAL
Intervention: Rectally insufflated CO2 with barium-based tagging (C)
Number of subjects: 14
Study 21440398 — intervention group
Group type: EXPERIMENTAL
Intervention: Rectally insufflated CO2 with iodine-based tagging (D)
Number of subjects: 14
Study 21440398 — intervention group
Group type: EXPERIMENTAL
Intervention: Rectally insufflated CO2
Number of subjects: 14
Study 18691937 — intervention group
Group type: EXPERIMENTAL
Intervention: Ramelteon 8 mg
Number of subjects: 289
Study 18691937 — intervention group
Group type: EXPERIMENTAL
Intervention: Ramelteon 16 mg
Number of subjects: 289
Study 18691937 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 289
Study 17227715 — intervention group
Group type: EXPERIMENTAL
Intervention: Implantable carotid sinus baroreflex activating system (CSL and IPG)
Number of subjects: 17
Study 17227715 — intervention group
Group type: EXPERIMENTAL
Intervention: Therapeutic electrical activation of the baroreflex system
Number of subjects: 17
Study 15998163 — intervention group
Group type: EXPERIMENTAL
Intervention: Sibutramine plus structured WMP
Number of subjects: 501
Study 15998163 — intervention group
Group type: COMPARATOR
Intervention: Only structured WMP
Number of subjects: 501
Study 12409969 — intervention group
Group type: EXPERIMENTAL
Intervention: Candesartan cilexetil (8-16 mg once daily)
Number of subjects: 239
Study 12409969 — intervention group
Group type: COMPARATOR
Intervention: Enalapril (10-20 mg once daily)
Number of subjects: 239
Study 12409969 — intervention group
Group type: EXPERIMENTAL
Intervention: Candesartan
Number of subjects: 239
Study 12409969 — intervention group
Group type: COMPARATOR
Intervention: Enalapril
Number of subjects: 239
Study 9816717 — intervention group
Group type: EXPERIMENTAL
Intervention: 4% lidocaine 6 ml at room temperature (Group B)
Number of subjects: 80
Study 9816717 — intervention group
Group type: EXPERIMENTAL
Intervention: 4% lidocaine 5 ml + 7% sodium bicarbonate 1 ml at room temperature (Group C)
Number of subjects: 80
Study 9816717 — intervention group
Group type: EXPERIMENTAL
Intervention: 4% lidocaine 5 ml + 7% sodium bicarbonate 1 ml warmed to 38 degrees C (Group D)
Number of subjects: 80
Study 9816717 — intervention group
Group type: COMPARATOR
Intervention: Normal saline 6 ml (Group A)
Number of subjects: 80
Study 7621841 — intervention group
Group type: EXPERIMENTAL
Intervention: Prednisolone 40 mg daily
Number of subjects: 12
Study 7621841 — intervention group
Group type: COMPARATOR
Intervention: Mianserin 60-90 mg daily
Number of subjects: 12
Study 1698185 — intervention group
Group type: EXPERIMENTAL
Intervention: Polychemotherapy (DTIC, vincristine, ftorafur, hydroxycarbamide) in clinical stage II
Number of subjects: 0
Study 1698185 — intervention group
Group type: COMPARATOR
Intervention: Single-agent chemotherapy (DTIC) in clinical stage I
Number of subjects: 0
Study 1698185 — intervention group
Group type: EXPERIMENTAL
Intervention: Polychemotherapy and Single-agent chemotherapy in clinical stage III
Number of subjects: 0
Study 6458872 — intervention group
Group type: EXPERIMENTAL
Intervention: Imipramine (75 mg/day)
Number of subjects: 10
Study 6458872 — intervention group
Group type: EXPERIMENTAL
Intervention: Zimelidine (200 mg/day)
Number of subjects: 10
Study 6458872 — intervention group
Group type: COMPARATOR
Intervention: Zimelidine (100 mg/day)
Number of subjects: 10
Study 31021313 — intervention group
Group type: EXPERIMENTAL
Intervention: Economic message
Number of subjects: 0
Study 31021313 — intervention group
Group type: EXPERIMENTAL
Intervention: Health message
Number of subjects: 0
Study 31021313 — intervention group
Group type: EXPERIMENTAL
Intervention: Gain framed message
Number of subjects: 0
Study 31021313 — intervention group
Group type: EXPERIMENTAL
Intervention: Loss framed message
Number of subjects: 0
Study 29101117 — intervention group
Group type: EXPERIMENTAL
Intervention: Double-dose clopidogrel (600 mg day 1; 150 mg days 2-7; then 75 mg daily)
Number of subjects: 17263
Study 29101117 — intervention group
Group type: COMPARATOR
Intervention: Standard-dose clopidogrel (300 mg day 1; then 75 mg daily)
Number of subjects: 17263
Study 29101117 — intervention group
Group type: EXPERIMENTAL
Intervention: Double-dose clopidogrel
Number of subjects: 17263
Study 29101117 — intervention group
Group type: COMPARATOR
Intervention: Standard-dose clopidogrel
Number of subjects: 17263
Study 26317528 — intervention group
Group type: EXPERIMENTAL
Intervention: PCM plus TENS
Number of subjects: 241
Study 26317528 — intervention group
Group type: COMPARATOR
Intervention: PCM
Number of subjects: 241
Study 25135030 — intervention group
Group type: EXPERIMENTAL
Intervention: spring steel insole
Number of subjects: 33
Study 25135030 — intervention group
Group type: COMPARATOR
Intervention: ordinary control insole
Number of subjects: 33
Study 22254226 — intervention group
Group type: EXPERIMENTAL
Intervention: rhBMP‐2/ACS + Bio‐Oss
Number of subjects: 0
Study 22254226 — intervention group
Group type: COMPARATOR
Intervention: Bio‐Oss
Number of subjects: 0
Study 19443826 — intervention group
Group type: EXPERIMENTAL
Intervention: 12-week twice-weekly heart health program
Number of subjects: 80
Study 19443826 — intervention group
Group type: COMPARATOR
Intervention: Delayed-intervention control group
Number of subjects: 80
Study 17439881 — intervention group
Group type: EXPERIMENTAL
Intervention: Normal-appearing white matter (NAWM) T(1) relaxation time
Number of subjects: 23
Study 17439881 — intervention group
Group type: EXPERIMENTAL
Intervention: Grey matter (GM) T(1) relaxation time
Number of subjects: 23
Study 17439881 — intervention group
Group type: EXPERIMENTAL
Intervention: Follow-up measurements of NAWM and GM T(1)
Number of subjects: 23
Study 17439881 — intervention group
Group type: EXPERIMENTAL
Intervention: Patient NAWM peak-height
Number of subjects: 23
Study 17439881 — intervention group
Group type: COMPARATOR
Intervention: Control GM peak-height
Number of subjects: 23
Study 15026868 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral alcohol (0.3 g/kg in 250 mL water)
Number of subjects: 10
Study 15026868 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous alcohol (7.5 mg/kg/minute in 250 mL saline for 40 minutes)
Number of subjects: 10
Study 15026868 — intervention group
Group type: COMPARATOR
Intervention: Control (saline 250 mL infused for 40 minutes)
Number of subjects: 10
Study 15026868 — intervention group
Group type: EXPERIMENTAL
Intervention: Both oral and intravenous alcohol
Number of subjects: 10
Study 12611172 — intervention group
Group type: EXPERIMENTAL
Intervention: Intranasal administration of V2 vasopressin receptor agonist (1‐desamino‐8‐D‐arginin‐vasopressin)
Number of subjects: 0
Study 11477842 — intervention group
Group type: EXPERIMENTAL
Intervention: Salvia Miltiorrhizae Composita (SMC) administered intravenously (16 ml) before NTG utilization
Number of subjects: 16
Study 11477842 — intervention group
Group type: COMPARATOR
Intervention: Control group (NTG only)
Number of subjects: 16
Study 7666271 — intervention group
Group type: EXPERIMENTAL
Intervention: Experimental group using a cradle with motion, sound, tactile (containment), and reduced-light stimuli.
Number of subjects: 90
Study 7666271 — intervention group
Group type: COMPARATOR
Intervention: Control group using an identical cradle with no stimulus modulation features.
Number of subjects: 90
Study 2572475 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketoconazole orally (400 mg/day for 5 days)
Number of subjects: 45
Study 2572475 — intervention group
Group type: COMPARATOR
Intervention: Nystatin vaginal pessaries (100,000 units twice/day for 7 days)
Number of subjects: 45
Study 163931 — intervention group
Group type: EXPERIMENTAL
Intervention: Aspirin treatment
Number of subjects: 0
Study 163931 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 31317939 — intervention group
Group type: EXPERIMENTAL
Intervention: Early closure of ileostomy (in 8‐13 days after surgery)
Number of subjects: 65
Study 31317939 — intervention group
Group type: COMPARATOR
Intervention: Delayed closure of ileostomy (after 12 weeks)
Number of subjects: 65
Study 31317939 — intervention group
Group type: EXPERIMENTAL
Intervention: Early closure of ileostomy
Number of subjects: 65
Study 31317939 — intervention group
Group type: COMPARATOR
Intervention: Delayed closure of ileostomy
Number of subjects: 65
Study 29250537 — intervention group
Group type: EXPERIMENTAL
Intervention: Halometasone cream (15g daily for 7-14 days) in Group A
Number of subjects: 60
Study 29250537 — intervention group
Group type: EXPERIMENTAL
Intervention: Halometasone cream (20g daily for 7-14 days) in Group B
Number of subjects: 60
Study 29250537 — intervention group
Group type: EXPERIMENTAL
Intervention: Halometasone cream (30g daily for 7-14 days) in Group C
Number of subjects: 60
Study 26151563 — intervention group
Group type: EXPERIMENTAL
Intervention: DayWhite (14% hydrogen peroxide whitening material containing potassium nitrate)
Number of subjects: 50
Study 26151563 — intervention group
Group type: EXPERIMENTAL
Intervention: PreviDent 5000 Sensitive (desensitizing toothpaste)
Number of subjects: 50
Study 26151563 — intervention group
Group type: EXPERIMENTAL
Intervention: Relief ACP (desensitizing gel)
Number of subjects: 50
Study 26151563 — intervention group
Group type: EXPERIMENTAL
Intervention: UltraEZ (desensitizing gel)
Number of subjects: 50
Study 26151563 — intervention group
Group type: COMPARATOR
Intervention: Control (30-minute treatment without any treatment material)
Number of subjects: 50
Study 22315153 — intervention group
Group type: EXPERIMENTAL
Intervention: Sensodyne® Rapid Relief (8% strontium acetate, 1040 ppm sodium fluoride)
Number of subjects: 28
Study 22315153 — intervention group
Group type: EXPERIMENTAL
Intervention: Colgate® Sensitive Pro‐ReliefTM daily (8% arginine, 1450 ppm sodium monofluorophosphate)
Number of subjects: 28
Study 22315153 — intervention group
Group type: COMPARATOR
Intervention: Standard toothpaste (1450 ppm sodium fluoride)
Number of subjects: 28
Study 22315153 — intervention group
Group type: COMPARATOR
Intervention: Water
Number of subjects: 28
Study 21545981 — intervention group
Group type: EXPERIMENTAL
Intervention: Ezetimibe add-on therapy
Number of subjects: 109
Study 21545981 — intervention group
Group type: COMPARATOR
Intervention: No-ezetimibe group
Number of subjects: 109
Study 19516150 — intervention group
Group type: EXPERIMENTAL
Intervention: Nutrition plus combination of aerobic and strength training (N + CAST)
Number of subjects: 41
Study 19516150 — intervention group
Group type: COMPARATOR
Intervention: Nutrition only (N)
Number of subjects: 41
Study 19516150 — intervention group
Group type: EXPERIMENTAL
Intervention: Nutrition plus strength training (N + ST)
Number of subjects: 41
Study 17650536 — intervention group
Group type: EXPERIMENTAL
Intervention: Integrated Psychological Therapy (IPT) program
Number of subjects: 56
Study 17650536 — intervention group
Group type: COMPARATOR
Intervention: Treatment as usual (control group)
Number of subjects: 56
Study 15555002 — intervention group
Group type: EXPERIMENTAL
Intervention: Alosetron 1 mg twice daily
Number of subjects: 714
Study 15555002 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 714